Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.29M Buy
12,286
+2,342
+24% +$415K 0.33% 79
2017
Q2
$1.71M Buy
9,944
+2,601
+35% +$423K 0.25% 146
2017
Q1
$1.21M Sell
7,343
-1,419
-16% -$236K 0.24% 157
2016
Q4
$1.28M Sell
8,762
-1,739
-17% -$262K 0.3% 97
2016
Q3
$1.75M Buy
10,501
+1,358
+15% +$230K 0.37% 46
2016
Q2
$1.39M Buy
9,143
+2,826
+45% +$439K 0.34% 67
2016
Q1
$947K Buy
6,317
+1,364
+28% +$203K 0.25% 143
2015
Q4
$804K Sell
4,953
-4,291
-46% -$674K 0.23% 171
2015
Q3
$1.28M Sell
9,244
-21,968
-70% -$3.46M 0.3% 94
2015
Q2
$4.79M Buy
31,212
+6,965
+29% +$1.12M 0.61% 30
2015
Q1
$3.88M Buy
24,247
+6,523
+37% +$1.03M 0.53% 44
2014
Q4
$2.82M Buy
+17,724
New +$2.76M 0.57% 33

Other funds holding AMGN

GAM Systematic's AMGN Position: Q3 2017 in Review

GAM Systematic increased its Amgen (AMGN) stake by 24% in Q3 2017, buying an estimated $415K and bringing the position to 12,286 shares worth $2.29M. The position accounts for 0.33% of the portfolio, ranked #79.

GAM Systematic first reported a position in AMGN in Q4 2014 and has held it in 12 quarters since. The position peaked at $4.79M in Q2 2015. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • GAM Systematic held 12,286 shares of Amgen worth $2.29M as of Q3 2017.
  • GAM Systematic bought 2,342 Amgen shares in Q3 2017, an estimated $415K.
  • Amgen made up 0.33% of GAM Systematic's portfolio in Q3 2017, its #79 holding.
  • GAM Systematic first reported a position in Amgen in Q4 2014 and has held it in 12 quarters since.
  • GAM Systematic's Amgen position peaked at $4.79M in Q2 2015.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.